Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916
octreotide oralciclosporin

decreases absorption

Unknown Anecdotal
octreotide telotristatethyl

decreases exposure

Unknown Study
olanzapine levodopa

decreases effects

Unknown Anecdotal
olaparib aliskiren

increases exposure

Unknown Theoretical
olaparib antihistamines,non-sedating

increases exposure

Unknown Theoretical
olaparib colchicine

increases exposure

Unknown Theoretical
olaparib dabigatran

increases exposure

Unknown Theoretical
olaparib digoxin

increases exposure

Unknown Theoretical
olaparib docetaxel

increases exposure

Unknown Theoretical
olaparib everolimus

increases exposure

Unknown Theoretical
olaparib fexofenadine

increases exposure

Unknown Theoretical
olaparib loperamide

increases exposure

Unknown Theoretical
olaparib paclitaxel

increases exposure

Unknown Theoretical
olaparib sirolimus

increases exposure

Unknown Theoretical
olaparib statins

increases exposure

Unknown Theoretical
olaparib talazoparib

increases exposure

Unknown Theoretical
olaparib taxanes

increases exposure

Unknown Theoretical
olaparib thrombininhibitors

increases exposure

Unknown Theoretical
olaparib topotecan

increases exposure

Unknown Theoretical
olaparibpotentially combinedhormonalcontraceptives

affects efficacy

Unknown Theoretical
omeprazole cilostazol

increases exposure

Unknown Study
opicapone adrenalineepinephrine

increases risk of cardiovascularadverseeffects

Unknown Theoretical
opicapone loperamide

increases exposure

Unknown Study
opicapone noradrenalinenorepinephrine

increases risk of cardiovascularadverseeffects

Unknown Theoretical
opicapone repaglinide

increases exposure

Unknown Study
opicapone sympathomimetics,inotropic

increases risk of cardiovascularadverseeffects

Unknown Theoretical
opicapone sympathomimetics,vasoconstrictor

increases risk of cardiovascularadverseeffects

Unknown Theoretical
opioids drugsthatcauseserotoninsyndrome

increases risk of serotoninsyndrome

Unknown Theoretical
opioids seetablep

increases risk of serotoninsyndrome

Unknown Theoretical
oralaluminiumhydroxide chenodeoxycholicacid

decreases absorption

Unknown Study
oralaluminiumhydroxide theactivemetaboliteoforalbaloxavirmarboxil

decreases concentration

Unknown Theoretical
oralantacids chloroquine

decreases absorption

Unknown Theoretical
oralantacids deflazacort

decreases absorption

Unknown Theoretical
oralantacids ibandronate

decreases absorption

Unknown Theoretical
oralantacids immediatereleasetablets

decreases absorption

Unknown Theoretical
oralantacids levothyroxine

decreases absorption

Unknown Anecdotal
oralantacids oralacalabrutinib

decreases exposure

Unknown Study
oralantacids oralantimalarials

decreases absorption

Unknown Theoretical
oralantacids oralatazanavir

decreases absorption

Unknown Theoretical
oralantacids oralbisphosphonates

decreases absorption

Unknown Theoretical
oralantacids oralbosutinib

decreases absorption

Unknown Theoretical
oralantacids oralcabotegravir

decreases concentration

Unknown Theoretical
oralantacids oralceritinib

decreases absorption

Unknown Theoretical
oralantacids oralchloroquine

decreases absorption

Unknown Theoretical
oralantacids oralcholicacid

decreases absorption

Unknown Theoretical
oralantacids oralcorticosteroids

decreases absorption

Unknown Theoretical
oralantacids oraldeflazacort

decreases absorption

Unknown Theoretical
oralantacids oraldipyridamole

decreases absorption

Unknown Theoretical
oralantacids oralerlotinib

decreases absorption

Unknown Theoretical
oralantacids oralgefitinib

decreases exposure

Unknown Theoretical
Prev 1 ... 55 56 57 58 59 ... 79 Next
3916 interactions
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.